Skip to main content
. 2026 Jan 13;18(2):237. doi: 10.3390/cancers18020237
AUC Area Under Curve
BRT Bioradiotherapy
CI Confidence Interval
CLAIM Checklist for Artificial Intelligence in Medical Imaging
CPH Coz Proportional Hazards
CRT Chemoradiotherapy
CT Computed Tomography
DFS Disease-Free Survival
FO First Order
FDG Fluorodeoxyglucose
GLCM Grey-Level Co-Occurrence Matrix
GLDM Grey-Level Dependence Matrix
GLRLM Grey-Level Run-Length Matrix
GLSZM Grey-Level Size Zone Matrix
GTV Gross Tumour Volume
HNSCC Head and Neck Squamous Cell Carcinoma
HR Hazard Ratio
IBSI Image Biomarker Standardisation Initiative
ICC Intraclass Correlation Coefficient
IHC Immunohistochemistry
LASSO Least Absolute Shrinkage and Selection Operator
LC Local Control
LFS Laryngectomy-Free Survival
LSCC Laryngeal Squamous Cell Carcinoma
MRI Magnetic Resonance Imaging
mRMR Minimum Redundancy Maximum Relevance
MTV Metabolic Tumour Volume
NGTDM Neighbouring Grey-Tone Difference Matrix
OS Overall Survival
PCA Principal Component Analysis
PET Positron Emission Tomography
PFS Progression-Free Survival
Rad-score Radiomic score
ROC Receiver Operating Characteristic
RSF Random Survival Forest
SUV Standardised Uptake Value
SVM Support Vector Machine
SVM-SMOTE Support Vector Machine—Synthetic Minority Over-sampling Technique
TRIPOD Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis
VOI Volume of Interest
ZLNU Zone Length Non-Uniformity